search
Back to results

Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients

Primary Purpose

Food Allergy

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Partially Hydrolyzed Whey formula
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Food Allergy focused on measuring Food Allergy, Cows Milk Allergy

Eligibility Criteria

6 Months - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 0.5-18 years old
  • positive skin prick tests (SPT) or detectable serum milk specific IgE and a history of an allergic reaction to milk within 6 months before study screening; or milk-specific IgE level or SPT highly predictive for clinical reactivity (if ≤ 2 years old, sIgE >2 kU/L; if > 2 years old, a level >5 kU/L; SPT wheal diameter ≥ 3 mm)
  • a clinical reaction during the cows milk oral food challenge

Exclusion Criteria:

  • negative SPT and undetectable milk-specific sIgE
  • unstable asthma, allergic rhinitis, or atopic dermatitis
  • milk-induced eosinophilic gastroenteropathy
  • recent reaction to partially hydrolyzed whey formula
  • history of severe anaphylaxis with hypotension to cows milk
  • participation in any interventional study for the treatment of food allergy in the 6 months prior to screening visit
  • inhalant allergent immunotherapy that has not yet reached maintenance dosing
  • inability to discontinue antihistamines for skin testing, OFC
  • any systemic therapy which in the judgment of the investigator could be immunomodulatory in the 12 months prior to visit 1 (xolair, rituximab, chronic steroids, etc)
  • investigational drug use 90 days prior to visit 1 or intention to use during study period
  • the presence of any medical condition that the investigator deems incompatible with participation in the trial.
  • unable to understand and speak English

Sites / Locations

  • Icahn School of Medicine at Mount Sinai

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

partially hydrolyzed whey formula

No intervention

Arm Description

The group of patients who pass an oral food challenge to partially hydrolyzed whey formula and will be continued on it through out the study

Patients who do not pass an oral food challenge to partially hydrolyzed whey formula will continue on their prior diet of cows milk avoidance.

Outcomes

Primary Outcome Measures

Prevalence of partially hydrolyzed whey formula tolerance
Prevalence of partially hydrolyzed whey formula tolerance in cow's milk allergic patients - Identify patients who are cow's milk allergic but can tolerate a partially hydrolyzed whey formula

Secondary Outcome Measures

Time to resolution of cows milk allergy
Determine if ingestion of partially hydrolyzed whey formula accelerates the resolution of allergy to cow's milk.

Full Information

First Posted
March 19, 2015
Last Updated
December 6, 2016
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Société des Produits Nestlé (SPN)
search

1. Study Identification

Unique Protocol Identification Number
NCT02397876
Brief Title
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Official Title
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Société des Produits Nestlé (SPN)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Cow's milk (CM) allergy is the most common food allergy in children, affecting 2-3% of infants. In formula-fed infants with CM allergy, extensively hydrolyzed or amino acid-based infant formulas are typically recommended. These formulas are expensive and not palatable. For older patients with CM allergy, the standard of care is avoidance of all CM products. The investigators cared for a CM allergic patient who was able to tolerate partially hydrolyzed whey formula (pHWF), which tastes better and is less expensive than extensively hydrolyzed or amino-acid based formulas. There are likely other subjects who could similarly tolerate pHWF. Furthermore, it is possible that taking pHWF could accelerate tolerance of CM. The investigators aim to identify characteristics of CM allergic subjects who can tolerate pHWF and assess the degree to which taking pHWF accelerates CM tolerance.
Detailed Description
Specifically, subjects who have CM allergy will be enrolled. The investigators will perform an oral food challenge (OFC) to pHWF in each subject. Subjects who pass the challenge will be placed on pHWF for 2 years. Subjects who do not pass the challenge will receive routine care. The investigators will perform allergy skin testing, specific IgE measurement, other serologic assays, and longitudinal OFCs to profile subject characteristics in the two groups at baseline and over time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Food Allergy
Keywords
Food Allergy, Cows Milk Allergy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
partially hydrolyzed whey formula
Arm Type
Experimental
Arm Description
The group of patients who pass an oral food challenge to partially hydrolyzed whey formula and will be continued on it through out the study
Arm Title
No intervention
Arm Type
No Intervention
Arm Description
Patients who do not pass an oral food challenge to partially hydrolyzed whey formula will continue on their prior diet of cows milk avoidance.
Intervention Type
Other
Intervention Name(s)
Partially Hydrolyzed Whey formula
Other Intervention Name(s)
Gerber Good Start Formula
Intervention Description
Patients who tolerate partially hydrolyzed whey formula will be continued on this formula for two years. Patients who do not tolerate the formula will be continued on their prior diet of cows milk avoidance.
Primary Outcome Measure Information:
Title
Prevalence of partially hydrolyzed whey formula tolerance
Description
Prevalence of partially hydrolyzed whey formula tolerance in cow's milk allergic patients - Identify patients who are cow's milk allergic but can tolerate a partially hydrolyzed whey formula
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Time to resolution of cows milk allergy
Description
Determine if ingestion of partially hydrolyzed whey formula accelerates the resolution of allergy to cow's milk.
Time Frame
up to 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 0.5-18 years old positive skin prick tests (SPT) or detectable serum milk specific IgE and a history of an allergic reaction to milk within 6 months before study screening; or milk-specific IgE level or SPT highly predictive for clinical reactivity (if ≤ 2 years old, sIgE >2 kU/L; if > 2 years old, a level >5 kU/L; SPT wheal diameter ≥ 3 mm) a clinical reaction during the cows milk oral food challenge Exclusion Criteria: negative SPT and undetectable milk-specific sIgE unstable asthma, allergic rhinitis, or atopic dermatitis milk-induced eosinophilic gastroenteropathy recent reaction to partially hydrolyzed whey formula history of severe anaphylaxis with hypotension to cows milk participation in any interventional study for the treatment of food allergy in the 6 months prior to screening visit inhalant allergent immunotherapy that has not yet reached maintenance dosing inability to discontinue antihistamines for skin testing, OFC any systemic therapy which in the judgment of the investigator could be immunomodulatory in the 12 months prior to visit 1 (xolair, rituximab, chronic steroids, etc) investigational drug use 90 days prior to visit 1 or intention to use during study period the presence of any medical condition that the investigator deems incompatible with participation in the trial. unable to understand and speak English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Supinda Bunyavanich, MD, MPH
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
23273958
Citation
Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, Henning AK, Mayer L, Burks AW, Grishin A, Stablein D, Sampson HA. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013 Mar;131(3):805-12. doi: 10.1016/j.jaci.2012.10.060. Epub 2012 Dec 28.
Results Reference
background
PubMed Identifier
3151608
Citation
Jin YT. [Surgical treatment of post-traumatic enophthalmos (report of 5 cases)]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1987 Sep;3(3):184-6, 238. No abstract available. Chinese.
Results Reference
background
PubMed Identifier
4293047
Citation
Reed RJ, Hairston MA, Palomeque FE. The histologic identity of adenoma sebaceum and solitary melanocytic angiofibroma. Dermatol Int. 1966 Jan-Mar;5(1):3-11. doi: 10.1111/j.1365-4362.1966.tb05174.x. No abstract available.
Results Reference
background
PubMed Identifier
25577632
Citation
Lee TD, Gimenez G, Grishina G, Mishoe M, Sampson HA, Bunyavanich S. Profile of a milk-allergic patient who tolerated partially hydrolyzed whey formula. J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):116-8. doi: 10.1016/j.jaip.2014.06.021. Epub 2014 Aug 29. No abstract available.
Results Reference
background

Learn more about this trial

Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients

We'll reach out to this number within 24 hrs